西地尼布-话题@MedSci

#西地尼布#

7篇内容 | 1498人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2260743, encodeId=48d32260e4370, content=<a href='/topic/show?id=aca3904e8a8' target=_blank style='color:#2F92EE;'>#西地尼布#</a> <a href='/topic/show?id=41f54454653' target=_blank style='color:#2F92EE;'>#奥拉帕利#</a> <a href='/topic/show?id=7b2910612398' target=_blank style='color:#2F92EE;'>#度伐利尤单抗#</a> <a href='/topic/show?id=7806111e2630' target=_blank style='color:#2F92EE;'>#铂耐药卵巢癌#</a>, objectTitle=CLIN CANCER RES | 比较度伐利尤单抗、奥拉帕利和西地尼布单药治疗、联合治疗或化疗在铂耐药卵巢癌患者中的疗效：NRG-GY023试验, objectType=article, longId=872139, objectId=bb8a8e2139ab, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250415/1744719631745_6145188.jpg, objectUrl=/article/show_article.do?id=bb8a8e2139ab, replyNumber=0, likeNumber=19, createdTime=2025-04-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb8a8e2139ab, moduleTitle=CLIN CANCER RES | 比较度伐利尤单抗、奥拉帕利和西地尼布单药治疗、联合治疗或化疗在铂耐药卵巢癌患者中的疗效：NRG-GY023试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb8a8e2139ab)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190140, encodeId=a1372190140f6, content=<a href='/topic/show?id=aca3904e8a8' target=_blank style='color:#2F92EE;'>#西地尼布#</a> <a href='/topic/show?id=41f54454653' target=_blank style='color:#2F92EE;'>#奥拉帕利#</a> <a href='/topic/show?id=7806111e2630' target=_blank style='color:#2F92EE;'>#铂耐药卵巢癌#</a>, objectTitle=OCTOVA临床试验：奥拉帕利、化疗或奥拉帕利联合西地尼布在铂耐药卵巢癌患者中的随机II期研究结果, objectType=article, longId=815176, objectId=d6758151e66f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240228/1709124756107_6145188.png, objectUrl=/article/show_article.do?id=d6758151e66f, replyNumber=0, likeNumber=98, createdTime=2024-02-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d6758151e66f, moduleTitle=OCTOVA临床试验：奥拉帕利、化疗或奥拉帕利联合西地尼布在铂耐药卵巢癌患者中的随机II期研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6758151e66f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1743347, encodeId=b9c71e43347cd, content=<a href='/topic/show?id=aca3904e8a8' target=_blank style='color:#2F92EE;'>#西地尼布#</a>, objectTitle=Clin Cancer Res：西地尼布联合奥拉帕利治疗晚期铂耐药卵巢癌的疗效, objectType=article, longId=734952, objectId=a303e34952f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a303e34952f4, replyNumber=0, likeNumber=153, createdTime=2022-08-23, rootId=0, userName=bugit, userId=37e735095638, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a303e34952f4, moduleTitle=Clin Cancer Res：西地尼布联合奥拉帕利治疗晚期铂耐药卵巢癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a303e34952f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1743346, encodeId=5ce61e433462f, content=<a href='/topic/show?id=aca3904e8a8' target=_blank style='color:#2F92EE;'>#西地尼布#</a>, objectTitle=J Clin Oncol：奥拉帕利±西地尼布 vs 化疗治疗复发性铂敏感性卵巢癌, objectType=article, longId=301138, objectId=85c9301138b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85c9301138b8, replyNumber=0, likeNumber=115, createdTime=2022-10-25, rootId=0, userName=bugit, userId=37e735095638, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85c9301138b8, moduleTitle=J Clin Oncol：奥拉帕利±西地尼布 vs 化疗治疗复发性铂敏感性卵巢癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85c9301138b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1743345, encodeId=c62a1e43345c2, content=<a href='/topic/show?id=aca3904e8a8' target=_blank style='color:#2F92EE;'>#西地尼布#</a>, objectTitle=ESMO Open：西地尼布联合化疗治疗复发性卵巢癌的3期试验结果, objectType=article, longId=207454, objectId=c0a120e454b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0a120e454b7, replyNumber=0, likeNumber=106, createdTime=2021-12-27, rootId=0, userName=bugit, userId=37e735095638, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0a120e454b7, moduleTitle=ESMO Open：西地尼布联合化疗治疗复发性卵巢癌的3期试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0a120e454b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1743344, encodeId=5f261e4334491, content=<a href='/topic/show?id=aca3904e8a8' target=_blank style='color:#2F92EE;'>#西地尼布#</a>, objectTitle=Lancet oncol：西地尼布为肺泡软组织肉瘤患者带来新的治疗希望, objectType=article, longId=167665, objectId=a64816e66544, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a64816e66544, replyNumber=0, likeNumber=111, createdTime=2020-01-26, rootId=0, userName=bugit, userId=37e735095638, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a64816e66544, moduleTitle=Lancet oncol：西地尼布为肺泡软组织肉瘤患者带来新的治疗希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a64816e66544)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1743343, encodeId=deed1e43343ee, content=<a href='/topic/show?id=aca3904e8a8' target=_blank style='color:#2F92EE;'>#西地尼布#</a>, objectTitle=Lancet Oncol：CP化疗中加入西地尼布，治疗宫颈癌可提高疗效 (CIRCCa研究), objectType=article, longId=57905, objectId=837c5e9059c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=837c5e9059c, replyNumber=0, likeNumber=120, createdTime=2015-12-02, rootId=0, userName=bugit, userId=37e735095638, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=837c5e9059c, moduleTitle=Lancet Oncol：CP化疗中加入西地尼布，治疗宫颈癌可提高疗效 (CIRCCa研究), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=837c5e9059c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1743342, encodeId=d4d81e4334287, content=<a href='/topic/show?id=aca3904e8a8' target=_blank style='color:#2F92EE;'>#西地尼布#</a>, objectTitle=Lancet：西地尼布联合顺铂和吉西他滨不能改善晚期胆道癌患者, objectType=article, longId=53266, objectId=85715326639, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85715326639, replyNumber=0, likeNumber=114, createdTime=2015-11-17, rootId=0, userName=bugit, userId=37e735095638, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85715326639, moduleTitle=Lancet：西地尼布联合顺铂和吉西他滨不能改善晚期胆道癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85715326639)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1743341, encodeId=598b1e433410a, content=<a href='/topic/show?id=aca3904e8a8' target=_blank style='color:#2F92EE;'>#西地尼布#</a>, objectTitle=JCO：西地尼布治疗腺泡状软组织肉瘤效果积极, objectType=article, longId=18593, objectId=c0361859321, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0361859321, replyNumber=0, likeNumber=135, createdTime=2013-12-22, rootId=0, userName=bugit, userId=37e735095638, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0361859321, moduleTitle=JCO：西地尼布治疗腺泡状软组织肉瘤效果积极, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0361859321)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

西地尼布

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#西地尼布# #奥拉帕利# #度伐利尤单抗# #铂耐药卵巢癌#

CLIN CANCER RES | 比较度伐利尤单抗、奥拉帕利和西地尼布单药治疗、联合治疗或化疗在铂耐药卵巢癌患者中的疗效：NRG-GY023试验

2025-04-16

梅斯管理员 (审核中...)

前往app查看评论内容

#西地尼布# #奥拉帕利# #铂耐药卵巢癌#

OCTOVA临床试验：奥拉帕利、化疗或奥拉帕利联合西地尼布在铂耐药卵巢癌患者中的随机II期研究结果

2024-02-29发表于上海

bugit (审核中...)

前往app查看评论内容

#西地尼布#

Clin Cancer Res：西地尼布联合奥拉帕利治疗晚期铂耐药卵巢癌的疗效

2022-08-23

bugit (审核中...)

前往app查看评论内容

#西地尼布#

J Clin Oncol：奥拉帕利±西地尼布 vs 化疗治疗复发性铂敏感性卵巢癌

2022-10-25

bugit (审核中...)

前往app查看评论内容

#西地尼布#

ESMO Open：西地尼布联合化疗治疗复发性卵巢癌的3期试验结果

2021-12-27

bugit (审核中...)

前往app查看评论内容

#西地尼布#

Lancet oncol：西地尼布为肺泡软组织肉瘤患者带来新的治疗希望

2020-01-26

bugit (审核中...)

前往app查看评论内容

#西地尼布#

Lancet Oncol：CP化疗中加入西地尼布，治疗宫颈癌可提高疗效 (CIRCCa研究)

2015-12-02

bugit (审核中...)

前往app查看评论内容

#西地尼布#

Lancet：西地尼布联合顺铂和吉西他滨不能改善晚期胆道癌患者

2015-11-17

bugit (审核中...)

前往app查看评论内容

#西地尼布#

JCO：西地尼布治疗腺泡状软组织肉瘤效果积极

2013-12-22

科室
- - 订阅+
  - 更多科室
工具
服务